RATIONAL PHARMACOTHERAPY OF ARVI: NEW OPPORTUNITIES


DOI: https://dx.doi.org/10.18565/pharmateca.2018.3.40-45

A.A. Zaitsev (1), I.Ts. Kulagina (1), O.I. Klochkov (2)

1) Main Military Clinical Hospital n.a. N.N. Burdenko, Moscow, Russia; 2) Voronovsky Hospital of Moscow Healthcare Department, Moscow, Russia
The publication discusses the rational pharmacotherapy of acute respiratory viral infections (ARVI). The results of the evaluation of the clinical efficacy of Influnet in the treatment of acute respiratory viral infection in 84 adults are presented; the frequency of development of asthenic syndrome in patients with acute respiratory viral infection is analyzed. It is shown that, the use of combined drugs for symptomatic therapy of acute respiratory viral infections can successfully cope with the symptoms of the disease.
Keywords: acute respiratory viral infections, asthenic syndrome, succinic acid, Influnet

About the Autors


Corresponding author: A.A. Zaitsev – MD, Professor, Chief Pulmonologist of the Main Military Clinical Hospital n.a. N.N. Burdenko, Moscow, Russia; e-mail: a-zaicev@yandex.ru


Бионика Медиа